CNR Institutional Research Information System

DEL VECCHIO, SILVANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.404
NA - Nord America 975
EU - Europa 285
SA - Sud America 233
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 11
Totale 2.926
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 925
SG - Singapore 588
CN - Cina 336
BR - Brasile 183
VN - Vietnam 115
HK - Hong Kong 114
FR - Francia 83
KR - Corea 77
IT - Italia 70
BD - Bangladesh 52
NL - Olanda 44
JP - Giappone 32
DE - Germania 26
CA - Canada 18
IN - India 18
GB - Regno Unito 16
AR - Argentina 15
FI - Finlandia 14
CO - Colombia 12
EC - Ecuador 11
IL - Israele 10
MX - Messico 8
IQ - Iraq 7
PK - Pakistan 7
SA - Arabia Saudita 7
CR - Costa Rica 6
ES - Italia 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
CL - Cile 5
MY - Malesia 5
IE - Irlanda 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
EG - Egitto 3
ET - Etiopia 3
JM - Giamaica 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
MN - Mongolia 3
PH - Filippine 3
PL - Polonia 3
PY - Paraguay 3
RU - Federazione Russa 3
SE - Svezia 3
TR - Turchia 3
TT - Trinidad e Tobago 3
EE - Estonia 2
ID - Indonesia 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
PA - Panama 2
PT - Portogallo 2
SV - El Salvador 2
TW - Taiwan 2
UA - Ucraina 2
VE - Venezuela 2
AM - Armenia 1
AT - Austria 1
BB - Barbados 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
KE - Kenya 1
LC - Santa Lucia 1
LV - Lettonia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.916
Salva come PNG Salva come JPEG
Città #
Singapore 355
Santa Clara 303
Hefei 158
San Jose 117
Hong Kong 113
Ashburn 95
Seoul 77
Beijing 76
Lauterbourg 69
Ho Chi Minh City 44
Los Angeles 32
Hanoi 23
Tokyo 22
Chicago 19
Naples 18
Buffalo 13
Dallas 13
Frankfurt am Main 11
Helsinki 10
Minamishinagawa 10
São Paulo 10
New York 9
Milan 8
Brooklyn 7
Orem 7
Brasília 6
Munich 6
Queens 6
Tashkent 6
Atlanta 5
Belo Horizonte 5
Bengaluru 5
Can Tho 5
Guayaquil 5
Rio de Janeiro 5
Springfield 5
Baghdad 4
Bauru 4
Biên Hòa 4
Boston 4
Charlotte 4
Council Bluffs 4
Crowley 4
Da Nang 4
Dublin 4
Düsseldorf 4
Jeddah 4
Memphis 4
Miami 4
Nha Trang 4
Philadelphia 4
Poplar 4
Rome 4
Thái Bình 4
Toronto 4
Amman 3
Amsterdam 3
Baku 3
Baltimore 3
Benito Juarez 3
Caruaru 3
Casandrino 3
Chennai 3
Curitiba 3
Dhaka 3
Guangzhou 3
Houston 3
Joinville 3
Jundiaí 3
Killeen 3
Kuala Lumpur 3
London 3
Manaus 3
Phoenix 3
Quito 3
Quận Một 3
Riyadh 3
San Antonio 3
San José 3
Stockholm 3
Turku 3
Ulan Bator 3
Abbeville 2
Addis Ababa 2
Amherst 2
Aracaju 2
Aurora 2
Bari 2
Belleville 2
Belém 2
Birmingham 2
Bonito 2
Bridgewater 2
Campos dos Goytacazes 2
Catanduva 2
Chisinau 2
Criciúma 2
Elmont 2
Faisalabad 2
Fort Lauderdale 2
Totale 1.871
Salva come PNG Salva come JPEG
Nome #
IN VITRO AND IN VIVO CHARACTERIZATION OF INDIUM-111 AND TECHNETIUM-99M LABELED CCK-8 DERIVATIVES FOR CCK-B RECEPTOR IMAGING. 102
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma 99
18F-FLT PET/CT imaging and inhibition of multiple signaling pathways downstream EGFR and MET receptors in resistant NSCLC 79
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by F-18-fluorothymidine 72
Bone Scintigraphy and SPECT/CT in Bisphosphonate-Induced Osteonecrosis of the Jaw 70
Gefitinib, a selective, tyrosine kinase inhibitor increases 99mTc-MIBI uptake in Bcl-2 overexpressing breast cancer cells. 68
Molecular imaging of tumor microenvironment FOREWORD 65
Multimodal imaging of tumor invasion by targeting integrin ?v?3 in a preclinical model of lung metastasis 64
Bone Marrow uptake of 99mTc-MIBI in patients with multiple myeloma 62
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 59
Preclinical imaging for targeting cancer immune evasion 59
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 58
3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer 58
Preclinical Imaging in Targeted Cancer Therapies 54
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer. 48
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 47
Molecular imaging of drug resistance in cancer 47
Monitoring the effects of combined treatment with EGFR and MET inhibitors in non-small cell lung cancer and synergy quantification by 18F-FLT PET/CT 46
PET/CT in cancer research: from preclinical to clinical applications 45
In Vitro and In Vivo Evaluation of 111In- DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging 45
99mTc-MIBI in the evaluation of breast cancer biology 45
Dynamic coupling of 99mtc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients 45
PET/CT in radiation oncology 44
18F-FLT PET/CT imaging of inositol trisphosphate receptor type 3-mediated enhancement of EGFR and MET co-targeting efficacy in non-small cell lung cancer 43
Combined 18F-FDG-PET/CT and 111In-Octreotide SPECT for Evaluation of Thymic Epithelial Tumors 43
Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives 42
Preclinical imaging in oncology: advances and perspectives 42
Usefulness of [In-111-DTPA(0)] octreotide scintigraphy in a family with von Hippel-Lindau disease 42
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 41
Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease. 41
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 41
18F-FLT PET/CT as a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 40
Evaluation of metabolic response with F-18-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors 40
Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells 39
Poorly diifferentiated small cell neuroendocrinecarcinoma localized in three different endocrine glands: Response to chemoteraphy and octreotide LAR. 38
MIBI as prognostic factor in breast cancer. 38
Radiolabeling approaches for cholecystokinin B receptor imaging 38
Washout of 99mTc-Sestamibi in predicting response to chemoterapy in patients with multiple myeloma 38
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. 37
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging 36
Nuclear imaging of apoptosis in animal tumor models 36
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma 36
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 35
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma 34
Nuclear imaging in cancer theranostics 34
AN IMPROVED RADIOLABELING SYNTHESIS OF RGDECHI WITH 18F-FLUORIDE. 33
In vivo imaging of alpha(v)beta(3) integrin expression with a radiolabeled chimeric RGD peptide 33
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-X-L modulation of inositol trisphosphate receptor type 3 32
Targeting avb3 integrin receptor by a new and selective peptide antagonist for tumour imaging and radionuclide therapy 32
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer 32
Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma 32
Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma. 31
A New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 31
IMAGING IN VIVO DELL'ESPESSIONE DELL'INTEGRINA alfa(v)beta(3) CON UN PEPTIDE CHIMERICO RGD RADIOMARCATO 30
A NEW AND SELECTIVE RADIOLABELED ALPHAVBETA3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS. 30
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. 30
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer 29
99mTc-MIBI in the evaluation of breast cancer biology 29
Inhibition of early (99m)Tc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma 29
Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines 28
Bone Scintigraphy and SPECT/CT in Bisphosphonate-Induced Osteonecrosis of the Jaw 28
Use of 99mTc-sestamibi scintigraphy in multiple myeloma. 28
In Vitro and In Vivo Evaluation of 111In- DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging 27
Molecular imaging of tumor microenvironment: challenges and perspectives 27
PET/CT in cancer research: from preclinical to clinical applications 26
Technetium 99m sestamibi in multiple myeloma 26
A new role for nuclear medicine in multiple myeloma 25
New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 25
A NEW AND SELECTIVE RADIOLABELLED v 3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS 18
Totale 2.926
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.420
article - articoli 8.911
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 324
Totale 19.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202429 0 0 0 0 0 0 0 0 1 7 16 5
2024/20251.055 4 5 77 47 297 24 47 16 30 62 236 210
2025/20261.526 103 158 126 215 285 59 238 50 83 91 79 39
2026/2027316 65 84 167 0 0 0 0 0 0 0 0 0
Totale 2.926